Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...

CNCure’s approach to cancer treatment utilizes genetically engineered ... Among CNCure’s pipeline are CNC-101 and CNC-105, two bacteria-based cancer immunotherapeutic (BCIT) candidates for ...

When Anne Maldzinski underwent a blood stem-cell transplant to cure her cancer, the procedure triggered a life-threatening ...

“We’re working with investigators at MD Anderson and around the world to derive novel microbiome-based strategies to improve immunity and responses to cancer treatment.” "There's growing ...

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

This finding helps explain why previous attempts to use bacterial therapy against ... help establish bacteria-based treatments as a mainstream approach to fighting cancer.

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

While more research is needed, current results suggest that certain antibiotics that disrupt the gut microbiome could modulate treatment ... based on their effects on the gut microbiome of cancer ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...